Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor and tumor-related disease areas with unmet medical needs, including COVID-19, prostate, breast and liver cancers, alopecia and acne. For more information, visit www.kintor.com.cn.
| Website | https://www.kintor.com.cn/ |
| Revenue | $6.4 million |
| Employees | 29 (9 on RocketReach) |
| Founded | 2009 |
| Phone | +86 512 6295 6307 |
| Technologies |
JavaScript
,
HTML
,
Bootstrap
+2 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Biopharma, Drug Discovery, Health Care, Science and Engineering, Life Science, Pharmaceutical |
| Competitors | Apexigen, AstraZeneca, Bayer, CanSino Biologics Inc.康希诺生物, WuXi AppTec, 百济神州医药信息咨询(上海)有限公司, Sino Biopharmaceutical Limited, Innovent Biologics, Eisai Co., Ltd., Bristol Myers Squibb +43 more (view full list) |
Looking for a particular Kintor Pharmaceutical Limited employee's phone or email?
The Kintor Pharmaceutical Limited annual revenue was $6.4 million in 2026.
Luke Cheung is the CFO of Kintor Pharmaceutical Limited.
9 people are employed at Kintor Pharmaceutical Limited.